"L. sericata" has been of medical importance since 1826, when Meigen removed larvae from the eyes and facial cavities of a human patient. "L. sericata" has shown promise in three separate clinical approaches. First, larvae have been shown to debride wounds with extremely low probability of myiasis upon clinical application. Larval secretions have been shown to help in tissue regeneration. "L. sericata" has also been shown to lower bacteremia levels in patients infected with MRSA. Essentially, "L. sericata" larvae can be used as biosurgery agents in cases where antibiotics and surgery are impractical.